46
CHAFFIN, M.K.; SCHUMACHER, J.; HOOPER, N. Multicentric cutaneous pythiosis
in a foal. Journal of the American Veterinary Medical Association. v. 201, n. 2, p.
310-312, 1992.
CHAFFIN, M.K.; SCHUMACHER, J.; MCMULLAN, W.C. Cutaneous pythiosis in the
horse. Veterinary Clinics of North America: Equine Practice. v. 11, n. 1, p. 91-103,
1995.
CHAIPRASERT, A. et al. Induction of zoospore formation in Thai isolates of Pythium
insidiosum. Mycoses. v. 33, n. 6, p. 317-323, 1990.
COSTA, E.O. & GÓRNIAK, S.L. Agentes Antifúngicos e Antivirais. In: SPINOSA,
H.S.; GÓRNIAK, S.L.; BERNARDI, M.M. Farmacologia Aplicada à Medicina
Veterinária. 3
a
ed, Rio de Janeiro: Guanabara Koogan, 2002, p. 430-442.
CUENCA-ESTRELLA, M. et al. Comparative in-vitro activity of voriconazole (UK-
109,496) and six other antifungal agents against clinical isolates of Scedosporium
prolificans and Scedosporium apiospermum. Journal of Antimicrobial
Chemotherapy. v. 43, p. 149-151, 1999.
CUENCA-ESTRELLA, M. & RODRÍGUEZ-TUDELA, J.L. ¿Pueden basarse las
indicaciones de los antifúngicos en los estudios de sensibilidad? Rev. Iberoam. Micol.
v. 19, p. 133-138, 2002.
CUENCA-ESTRELLA, M. Combinations of antifungal agents in therapy–what value
are they? Journal of Antimicrobial Chemotherapy. v. 54, p. 854–869, 2004.
DAVIS, R. & BALFOUR, J.A. Terbinafine. A pharmacoeconomic evaluation of its use
in superficial fungal infections. Pharmacoeconomics. v. 8, n. 3, p. 253-269, 1995.
DE COCK, A.W. et al. Pythium insidiosum sp. nov. the etiologic agent of pythiosis.
Journal of Clinical Microbiology. v. 25, n. 2, p. 344-349, 1987.
DIEKEMA, D.J. et al. Activities of Caspofungin, Itraconazole, Pozaconazole,
Ravuconazole, Voriconazole, and Amphotericin B against 488 Recent Clinical Isolates
of Filamentous Fungi. Journal of Clinical Microbiology. v. 41, n. 8, p. 3623-3626,
2003.
DYKSTRA, M.J. et al. A description of cutaneous-subcutaneous pythiosis in fifteen
dogs. Medical Mycology. v. 37, n. 6, p. 427-433, 1999.